SpasmoCalm fights the pain

SpasmoCalm fights the pain

Previous slide
Next slide

Therapeutic indications

Smooth muscle spasm associated with biliary diseases: gallstones, cholangiolithiasis, cholecystitis, pericholecystitis, cholangitis, papillitis.

Spasm of the urinary tract muscles associated with kidney diseases: renal lithiasis, ureterolithiasis, pyelitis, cystitis, bladder tenesmus.
It can be used as an associated treatment in:

Smooth muscle spasms caused by gastrointestinal disorders: gastric or duodenal ulcer, gastritis, enteritis, colitis, cardiac or pyloric sphincter spasm, irritable bowel syndrome, spastic constipation or flatulence, pancreatitis.

In gynecological conditions: dysmenorrhea, adnexitis, intense pain during labor, uterine contractions, impending abortion.

Doses and method of administration


One tablet contains drotaverine hydrochloride 40 mg and excipients: lactose monohydrate, corn starch, polyvidone K30, magnesium stearate, talc.

Pharmacotherapeutic group

Medicines in the treatment of intestinal functional disorders, papaverine and derivatives.

Pregnancy and breastfeeding

Animal reproduction studies have shown that drotaverine does not affect pregnancy and has no teratogenic or embryotoxic properties.